Glucagon-Like Peptide-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and Indication

Key Points

• Out-of-pocket costs for glucagon-like peptide-1 receptor agonists varied by race and ethnicity, highlighting disparities in health access.
• The study found significant differences in how often prescriptions for these medications were filled, particularly among different racial groups.
• A cohort study assessed prescription fulfillment rates and associated costs for patients prescribed glucagon-like peptide-1 receptor agonists.
• Health equity may be impacted by race and ethnicity in the utilization of glucagon-like peptide-1 receptor agonists, suggesting a need for targeted interventions.